Limited coverage drugs – pamidronate

Last updated on September 26, 2024

Generic name / strength / form

pamidronate – all strengths and forms

Criteria

Approval period

Diagnosis indicating bone metastases associated with cancer (except breast cancer).

1 year

Practitioner exemptions

  • No practitioner exemptions

Special notes

  • None

Special Authority requests